Project Details
Description
A 52-week, randomized, double-blind, placebo-controlled, multi-center, parallel-group study of ...Agomelatine
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/07 → 3/31/10 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.